Mankind Pharma Limited Operating Cash Flow for the year ending March 31, 2025: USD 282.41 M

Mankind Pharma Limited Operating Cash Flow is USD 282.41 M for the year ending March 31, 2025, a 9.44% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Mankind Pharma Limited Operating Cash Flow for the year ending March 31, 2024 was USD 258.06 M, a 18.85% change year over year.
  • Mankind Pharma Limited Operating Cash Flow for the year ending March 31, 2023 was USD 217.13 M, a 79.25% change year over year.
  • Mankind Pharma Limited Operating Cash Flow for the year ending March 31, 2022 was USD 121.13 M, a -22.01% change year over year.
  • Mankind Pharma Limited Operating Cash Flow for the year ending March 31, 2021 was USD 155.31 M, a 9.41% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities